Making sorafenib irresistible:In vivoscreening for mechanisms of therapy resistance in hepatocellular carcinoma hits on Mapk14-Reference-Cited by-同舟云学术

Making sorafenib irresistible:In vivoscreening for mechanisms of therapy resistance in hepatocellular carcinoma hits on Mapk14

Published:2015-03-20 Issue:5 Volume:61 Page:1755-1757
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Avila Matias¹,Berasain Carmen¹

Affiliation:

1. Center for Applied Medical Research (CIMA); Division of Hepatology; University of Navarra; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd); Instituto de Investigaciones Sanitarias de Navarra (IDISNA); University Clinic Navarra, Instituto de Salud Carlos III; Navarra Spain

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.27739/fullpdf

Reference8 articles.

1. Hepatocellular carcinoma and sorafenib: too many resistance mechanisms?;Berasain;Gut,2013

2. In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer;Rudalska;Nat Med,2014

3. Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by oncogenomic screening;Sawey;Cancer Cell,2011

4. Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironment;Giannelli;Gut,2014

5. Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development;Uriarte;Int J Cancer,2014

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aldehyde Dehydrogenase 2 (ALDH2): A novel sorafenib target in hepatocellular carcinoma unraveled by the proteome-wide cellular thermal shift assay;SLAS Discovery;2024-04

2. Molecular mechanisms of microRNA-216a during tumor progression;Cancer Cell International;2023-02-05

3. DDX24 regulates the chemosensitivity of hepatocellular carcinoma to sorafenib via mediating the expression of SNORA18;Cancer Biology & Therapy;2022-10-30

4. ATF2 accelerates the invasion and metastasis of hepatocellular carcinoma through targeting the miR‐548p/TUFT1 axis;Hepatology Research;2022-01-15

5. RNA polymerase II subunit 3 regulates vesicular, overexpressed in cancer, prosurvival protein 1 expression to promote hepatocellular carcinoma;Journal of International Medical Research;2021-04